|
Volumn 356, Issue 1, 2007, Pages 86-87
|
Immunotherapy with a ragweed vaccine [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
OLIGODEOXYRIBONUCLEOTIDE;
PLACEBO;
RAGWEED ANTIGEN;
ALLERGEN;
AMB A I PROTEIN, AMBROSIA ARTEMISIIFOLIA;
SODIUM CHLORIDE;
UNCLASSIFIED DRUG;
VEGETABLE PROTEIN;
AMB A 1 ANTIGEN;
CXCL9 CHEMOKINE;
GAMMA INTERFERON;
GAMMA INTERFERON INDUCIBLE PROTEIN 10;
INTERLEUKIN 5;
STREPTOKINASE;
THYMUS AND ACTIVATION REGULATED CHEMOKINE;
DNA VACCINE;
ALLERGIC DISEASE;
ASTHMA;
DNA SEQUENCE;
DRUG ACTIVITY;
DRUG EFFICACY;
HUMAN;
IMMUNOSTIMULATION;
IMMUNOTHERAPY;
LETTER;
PRIORITY JOURNAL;
ACTIVE IMMUNIZATION;
COMPARATIVE STUDY;
HAY FEVER;
IMMUNOLOGY;
NOTE;
RAGWEED;
ALLERGIC RHINITIS;
ANTIBODY TITER;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN SENSITIVITY;
SKIN TEST;
TH2 CELL;
HELPER CELL;
ALLERGENS;
AMBROSIA;
HUMANS;
IMMUNOTHERAPY, ACTIVE;
OLIGODEOXYRIBONUCLEOTIDES;
PLANT PROTEINS;
RHINITIS, ALLERGIC, SEASONAL;
SODIUM CHLORIDE;
T-LYMPHOCYTES, HELPER-INDUCER;
VACCINES, DNA;
|
EID: 33845991217
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc063014 Document Type: Letter |
Times cited : (2)
|
References (2)
|